Global Patent Strategies Biologics – Spotlight: Enablement and Patent Eligibility, It’s All in the Details Biologics key stakeholders face a dilemma: first-to-file versus a disclosure sufficient to enable and claim patent-eligible subject matter. In the decade since the enactment of the Biologics Price Competition and Innovation Act (BPCIA), patent protection for biologics has become increasingly important. In [...]
Date: Thursday, March 18, 12 pm Pacific. Topic: Spousal Ownership of Inventions and Patents in U.S. Community Property Jurisdictions Overview: A discussion of the interaction of 35 USC Sections 261 & 262 with state community property law on the ownership, exploitation, and assignment of invention rights, patent applications, and patents Speaker: John Land of Jaquez [...]
This column highlights some of the more notable recent online notices, newsletters, and blogs dealing with IP prosecution issues. Patently-O – a patent law blog – Patentlyo.com On September 28, 2020, David Hricik discussed the USPTO’s proposal for voluntary CLE for patent practitioners. Instead of charging a fee and providing a discount for patent-related CLE [...]
The Cardiovascular IP Landscape January 26, 2021, 12 pm - 1 pm via Zoom About Our Speakers: Christy Lea resolves high-stakes patent and trade secret disputes at both the trial and appellate levels. She has represented clients in the medical device and pharmaceutical industries for nearly two decades. Christy is also an accomplished PTAB [...]
Date: Thursday, January 7, 12:00 PM Pac. Location: Zoom - link to be sent after registration Topic: Introduction to the California Privacy Rights Act (CPRA) Presenters: Steven M. Millendorf, Senior Counsel and Kathryn Parsons-Reponte, Associate, Foley & Lardner LLP The California Privacy Rights Act (CPRA) was hidden far on the November ballot in California as [...]
